Kieran Gallahue
CIK: 0001308428
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 19, 2026NVST
Envista Holdings Corp
Award(A)Direct9.3K shares- - May 8, 2026EW
Edwards Lifesciences Corp
Award(A)Direct3.3K shares- - May 8, 2026EW
Edwards Lifesciences Corp
Award(A)Direct1.1K shares- - Jun 10, 2025NVST
Envista Holdings Corp
Award(A)Direct10.5K shares- - May 9, 2025EW
Edwards Lifesciences Corp
Award(A)Direct3.5K shares- - May 9, 2025EW
Edwards Lifesciences Corp
Award(A)Direct1.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 19, 2026 | NVST Envista Holdings Corp | Award(A) | 9,330 | - | $0 | Direct |
| May 8, 2026 | EW Edwards Lifesciences Corp | Award(A) | 3,251 | - | $0 | Direct |
| May 8, 2026 | EW Edwards Lifesciences Corp | Award(A) | 1,064 | - | $0 | Direct |
| Jun 10, 2025 | NVST Envista Holdings Corp | Award(A) | 10,450 | - | - | Direct |
| May 9, 2025 | EW Edwards Lifesciences Corp | Award(A) | 3,528 | - | - | Direct |
| May 9, 2025 | EW Edwards Lifesciences Corp | Award(A) | 1,154 | - | - | Direct |
1-6 of 6 transactions
About GALLAHUE KIERAN
GALLAHUE KIERAN (SEC CIK 0001308428) files insider reports with the SEC as Director of Envista Holdings Corp (NVST) and Director of Edwards Lifesciences Corp (EW).
Signal8 holds 4 ownership filings by GALLAHUE KIERAN, all Form 4s, filed between May 9, 2025 and May 21, 2026. Those filings report 6 transactions, from May 9, 2025 to May 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GALLAHUE KIERAN's filings is in IRVINE, CA.
Recent filings by GALLAHUE KIERAN
Other insiders filing for Envista Holdings Corp (NVST)
- Keel Paul A, Chairman and CEO
- Acurio Veronica, President, Orthodontics
- Befidi Robert, President, Diagnostics
- Hammes Eric D., Chief Financial Officer
- Nilsson Stefan, President, Nobel Biocare
- Reis Mischa, SVP, Strategy & Bus. Dev.